Compugen Ltd (CGEN)
2.15
+0.16
(+8.26%)
USD |
NASDAQ |
May 02, 16:00
2.15
0.00 (0.00%)
After-Hours: 16:09
Compugen Enterprise Value: 127.12M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 127.12M |
April 30, 2024 | 122.11M |
April 29, 2024 | 126.58M |
April 26, 2024 | 121.21M |
April 25, 2024 | 119.42M |
April 24, 2024 | 120.32M |
April 23, 2024 | 126.58M |
April 22, 2024 | 118.53M |
April 19, 2024 | 119.42M |
April 18, 2024 | 117.63M |
April 17, 2024 | 119.42M |
April 16, 2024 | 131.06M |
April 15, 2024 | 124.79M |
April 12, 2024 | 140.01M |
April 11, 2024 | 151.65M |
April 10, 2024 | 151.65M |
April 09, 2024 | 160.61M |
April 08, 2024 | 157.92M |
April 05, 2024 | 165.98M |
April 04, 2024 | 157.03M |
April 03, 2024 | 166.87M |
April 02, 2024 | 158.82M |
April 01, 2024 | 170.45M |
March 28, 2024 | 180.30M |
March 27, 2024 | 176.72M |
Date | Value |
---|---|
March 26, 2024 | 173.14M |
March 25, 2024 | 175.83M |
March 22, 2024 | 185.67M |
March 21, 2024 | 188.36M |
March 20, 2024 | 190.15M |
March 19, 2024 | 180.30M |
March 18, 2024 | 188.36M |
March 15, 2024 | 193.73M |
March 14, 2024 | 189.26M |
March 13, 2024 | 200.89M |
March 12, 2024 | 200.00M |
March 11, 2024 | 198.21M |
March 08, 2024 | 212.53M |
March 07, 2024 | 186.57M |
March 06, 2024 | 178.51M |
March 05, 2024 | 177.62M |
March 04, 2024 | 213.43M |
March 01, 2024 | 185.67M |
February 29, 2024 | 180.30M |
February 28, 2024 | 179.41M |
February 27, 2024 | 186.57M |
February 26, 2024 | 178.51M |
February 23, 2024 | 158.82M |
February 22, 2024 | 157.03M |
February 21, 2024 | 163.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.55M
Minimum
Sep 29 2022
1.472B
Maximum
Aug 25 2020
346.51M
Average
192.38M
Median
Feb 01 2022
Enterprise Value Benchmarks
Pluri Inc | 24.07M |
BioLine Rx Ltd | 20.50M |
XTL Biopharmaceuticals Ltd | 12.02M |
Can Fite Biofarma Ltd | 1.508M |
BiomX Inc | 20.83M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 9.713M |
Revenue (Quarterly) | 33.46M |
Total Expenses (Quarterly) | 15.48M |
EPS Diluted (Quarterly) | 0.12 |
Profit Margin (Quarterly) | 29.03% |
Earnings Yield | -9.77% |
Normalized Earnings Yield | -9.767 |